ID29574A - Formulasi 2-metil-tieno-benzodiazepin - Google Patents

Formulasi 2-metil-tieno-benzodiazepin

Info

Publication number
ID29574A
ID29574A IDW20010679A ID20010679A ID29574A ID 29574 A ID29574 A ID 29574A ID W20010679 A IDW20010679 A ID W20010679A ID 20010679 A ID20010679 A ID 20010679A ID 29574 A ID29574 A ID 29574A
Authority
ID
Indonesia
Prior art keywords
formulation
tieno
benzodiazepin
methyl
olanzapine
Prior art date
Application number
IDW20010679A
Other languages
English (en)
Indonesian (id)
Inventor
Charles Arthur Bunnell
Thomas Harry Ferguson
Barry Arnold Hendriksen
David Edward Tupper
Manuel Vicente Sanchez-Felix
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID29574A publication Critical patent/ID29574A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20010679A 1998-09-30 1999-03-24 Formulasi 2-metil-tieno-benzodiazepin ID29574A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation

Publications (1)

Publication Number Publication Date
ID29574A true ID29574A (id) 2001-09-06

Family

ID=26859927

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010679A ID29574A (id) 1998-09-30 1999-03-24 Formulasi 2-metil-tieno-benzodiazepin

Country Status (28)

Country Link
EP (1) EP1119359B1 (de)
JP (1) JP4551988B2 (de)
CN (1) CN1146422C (de)
AT (2) ATE267602T1 (de)
AU (1) AU759751B2 (de)
BR (1) BR9914156A (de)
CA (1) CA2344873A1 (de)
CZ (1) CZ302367B6 (de)
DE (2) DE69935873T2 (de)
DK (2) DK1119359T3 (de)
EA (1) EA002580B1 (de)
ES (2) ES2221376T3 (de)
GE (1) GEP20094818B (de)
HK (1) HK1041199B (de)
HR (1) HRP20010238B1 (de)
HU (1) HU227400B1 (de)
ID (1) ID29574A (de)
IL (2) IL141766A0 (de)
MY (1) MY126476A (de)
NO (1) NO328243B1 (de)
NZ (1) NZ510208A (de)
PL (1) PL196821B1 (de)
PT (2) PT1468689E (de)
SK (1) SK285944B6 (de)
TR (1) TR200100885T2 (de)
TW (1) TW577890B (de)
UA (1) UA66872C2 (de)
WO (1) WO2000018408A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1246827T3 (da) * 1999-12-28 2005-05-23 Cipla Ltd Nye polymorfe former af olanzapin
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
ES2289974T1 (es) * 2004-07-14 2008-02-16 Shasun Chemicals And Drugs Limited Metodo mejorado para producir la forma i de la olanzapina.
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
KR20130030305A (ko) * 2004-11-16 2013-03-26 엘란 파마 인터내셔널 리미티드 주사가능한 나노입자형 올란자핀 제형
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
US7932249B2 (en) * 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
CZ299218B6 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
WO2011060352A1 (en) * 2009-11-16 2011-05-19 Ipsen Pharma S.A.S. Pharmaceutical compositions of melanocortin receptor ligands
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
JP5893616B2 (ja) 2010-10-18 2016-03-23 大日本住友製薬株式会社 注射用徐放性製剤
EP2956456B1 (de) 2013-02-13 2017-07-12 Neuland Laboratories Ltd Verfahren zur herstellung von olanzapinpamoat
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
CA3057438A1 (en) * 2017-03-20 2018-09-27 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulaitons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095499A1 (en) * 1992-05-08 1993-11-09 Petrus J. M. Van Den Oetelaar Depot preparation
DK0669128T3 (da) * 1992-11-17 2000-06-19 Yoshitomi Pharmaceutical Sustained-release mikrosfære indeholdende antipsykotikum og fremgangsmåde til at fremstille samme
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
BR9711541A (pt) * 1996-09-23 1999-08-24 Lilly Co Eli Dihidrato d de olanzapina
UA73715C2 (en) * 1997-09-30 2005-09-15 Lilly Co Eli Pharmaceutically acceptable formulation of olanzapine pamoate and its use for treatment

Also Published As

Publication number Publication date
HK1041199A1 (en) 2002-07-05
PL346981A1 (en) 2002-03-11
HK1041199B (zh) 2005-03-18
HUP0103636A2 (hu) 2002-01-28
DE69917663T2 (de) 2005-05-25
CZ302367B6 (cs) 2011-04-13
UA66872C2 (uk) 2004-06-15
ES2285294T3 (es) 2007-11-16
SK4162001A3 (en) 2002-03-05
TR200100885T2 (tr) 2001-08-21
EA002580B1 (ru) 2002-06-27
PL196821B1 (pl) 2008-02-29
EA200100406A1 (ru) 2001-10-22
ATE359793T1 (de) 2007-05-15
DK1468689T3 (da) 2007-08-13
HRP20010238A2 (en) 2002-04-30
BR9914156A (pt) 2001-06-26
JP4551988B2 (ja) 2010-09-29
PT1468689E (pt) 2007-07-09
NO20011583D0 (no) 2001-03-28
NO20011583L (no) 2001-03-28
AU3362799A (en) 2000-04-17
DK1119359T3 (da) 2004-08-16
SK285944B6 (sk) 2007-11-02
TW577890B (en) 2004-03-01
HU227400B1 (en) 2011-05-30
MY126476A (en) 2006-10-31
HRP20010238B1 (en) 2006-05-31
JP2002525330A (ja) 2002-08-13
CN1146422C (zh) 2004-04-21
AU759751B2 (en) 2003-05-01
CZ20011149A3 (cs) 2002-01-16
DE69935873T2 (de) 2008-01-10
ES2221376T3 (es) 2004-12-16
CA2344873A1 (en) 2000-04-06
CN1320038A (zh) 2001-10-31
DE69935873D1 (de) 2007-05-31
HUP0103636A3 (en) 2003-05-28
GEP20094818B (en) 2009-11-10
NZ510208A (en) 2003-04-29
DE69917663D1 (de) 2004-07-01
EP1119359A1 (de) 2001-08-01
WO2000018408A1 (en) 2000-04-06
IL141766A0 (en) 2002-03-10
EP1119359A4 (de) 2001-12-19
IL141766A (en) 2006-12-31
PT1119359E (pt) 2004-08-31
NO328243B1 (no) 2010-01-11
ATE267602T1 (de) 2004-06-15
EP1119359B1 (de) 2004-05-26

Similar Documents

Publication Publication Date Title
TR200000812T2 (tr) 2-metil-tieno- benzodiazepin formülasyonu.
ATE359793T1 (de) 2-methyl-thieno-benzodiazepin formulierung
NO20010556L (no) Fremgangsmate for oftalmisk administrering
YU15499A (sh) Olanzapin dihidrat d
EA199900373A2 (ru) Фармацевтические композиции
TR199800759T2 (xx) Protein Kinaz C �nhibit�r�.
RS49688B (sr) Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
YU15299A (sh) Farmaceutski sastavi
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
IT1307928B1 (it) Metodo di sintesi di nitrossimetilfenil esteri di derivatidell'aspirina.
NL1006065A1 (nl) Inlegkruisje voor stringslip.
DK1073447T3 (da) N1-modificerede glycopeptider
ECSP992901A (es) Formulacion de 2- metil -tieno benzodiazepina
ECSP972052A (es) Quinoxalinadionas
ITMI982242A0 (it) Procedimento per la preparazione di un derivato dell'isobenzofurano
IT239670Y1 (it) Idro-contenitore per l'innalzamento provvisorio di argini.
IT1287349B1 (it) Pertica per il livellamento di superfici intonacate.
IT1287307B1 (it) Pertica per il livellamento di superfici intonacate.
ES2196503T3 (es) Procedimientos e intermedios para la preparacion de pirrolo(3,2-b)piridinas.
UA25365A (uk) Спосіб профілактики вториhhої катаракти
ECSP982785A (es) Nuevos compuestos de tetrahidroizoquinoleinil- carboxamida, de formula (i) y procedimiento para su obtencion
ITMI981691A1 (it) Composizioni farmaceutiche atte alla sommistrazione per via transdermale di apomorfina
ITMI970682A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4- tetraidroisochinolin-3- carbossiammide